Global Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Amyotrophic Lateral Sclerosis (ALS) Treatment market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Amyotrophic Lateral Sclerosis (ALS) Treatment market are covered in Chapter 9:
Biogen
BrainStorm Cell Limited
AB Science
Mitsubishi Tanabe Pharma Corporation
Biohaven Pharmaceutical
Sun Pharmaceutical Industries Ltd.
Amylyx Pharmaceuticals Inc.
Ionis Pharmaceuticals
CORESTEM, Inc
In Chapter 5 and Chapter 7.3, based on types, the Amyotrophic Lateral Sclerosis (ALS) Treatment market from 2017 to 2027 is primarily split into:
Riluzole
Edaravone
Tofersen/ BIIB067
Arimoclomol
Ultomiris (Ravulizumab)
Verdiperstat
Zilucoplan
CNM-Au8
Trehalose
MN-166
AMX0035
In Chapter 6 and Chapter 7.4, based on applications, the Amyotrophic Lateral Sclerosis (ALS) Treatment market from 2017 to 2027 covers:
Hospitals
Specialty Centers
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Amyotrophic Lateral Sclerosis (ALS) Treatment market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Amyotrophic Lateral Sclerosis (ALS) Treatment Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Amyotrophic Lateral Sclerosis (ALS) Treatment market are covered in Chapter 9:
Biogen
BrainStorm Cell Limited
AB Science
Mitsubishi Tanabe Pharma Corporation
Biohaven Pharmaceutical
Sun Pharmaceutical Industries Ltd.
Amylyx Pharmaceuticals Inc.
Ionis Pharmaceuticals
CORESTEM, Inc
In Chapter 5 and Chapter 7.3, based on types, the Amyotrophic Lateral Sclerosis (ALS) Treatment market from 2017 to 2027 is primarily split into:
Riluzole
Edaravone
Tofersen/ BIIB067
Arimoclomol
Ultomiris (Ravulizumab)
Verdiperstat
Zilucoplan
CNM-Au8
Trehalose
MN-166
AMX0035
In Chapter 6 and Chapter 7.4, based on applications, the Amyotrophic Lateral Sclerosis (ALS) Treatment market from 2017 to 2027 covers:
Hospitals
Specialty Centers
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Amyotrophic Lateral Sclerosis (ALS) Treatment market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Amyotrophic Lateral Sclerosis (ALS) Treatment Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 AMYOTROPHIC LATERAL SCLEROSIS (ALS) TREATMENT MARKET OVERVIEW
1.1 Product Overview and Scope of Amyotrophic Lateral Sclerosis (ALS) Treatment Market
1.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment by Type
1.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment by Application
1.3.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market, Region Wise (2017-2027)
1.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.4.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.4.4 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.4.5 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.4.6 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.4.8 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.5 Global Market Size of Amyotrophic Lateral Sclerosis (ALS) Treatment (2017-2027)
1.5.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Amyotrophic Lateral Sclerosis (ALS) Treatment Market
2 INDUSTRY OUTLOOK
2.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Drivers Analysis
2.4 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Development
3 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS (ALS) TREATMENT MARKET LANDSCAPE BY PLAYER
3.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Share by Player (2017-2022)
3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Market Share by Player (2017-2022)
3.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Average Price by Player (2017-2022)
3.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Gross Margin by Player (2017-2022)
3.5 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Competitive Situation and Trends
3.5.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Concentration Rate
3.5.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS (ALS) TREATMENT SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
4.5 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
4.6 China Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
4.7 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
4.8 India Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
4.9 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
4.10 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
4.11 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
5 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS (ALS) TREATMENT SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Market Share by Type (2017-2022)
5.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Market Share by Type (2017-2022)
5.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Price by Type (2017-2022)
5.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Riluzole (2017-2022)
5.4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Edaravone (2017-2022)
5.4.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Tofersen/ BIIB067 (2017-2022)
5.4.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Arimoclomol (2017-2022)
5.4.5 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Ultomiris (Ravulizumab) (2017-2022)
5.4.6 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Verdiperstat (2017-2022)
5.4.7 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Zilucoplan (2017-2022)
5.4.8 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of CNM-Au8 (2017-2022)
5.4.9 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Trehalose (2017-2022)
5.4.10 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of MN-166 (2017-2022)
5.4.11 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of AMX0035 (2017-2022)
6 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS (ALS) TREATMENT MARKET ANALYSIS BY APPLICATION
6.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Market Share by Application (2017-2022)
6.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Growth Rate of Specialty Centers (2017-2022)
6.3.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS (ALS) TREATMENT MARKET FORECAST (2022-2027)
7.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Price and Trend Forecast (2022-2027)
7.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Riluzole (2022-2027)
7.3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Edaravone (2022-2027)
7.3.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Tofersen/ BIIB067 (2022-2027)
7.3.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Arimoclomol (2022-2027)
7.3.5 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Ultomiris (Ravulizumab) (2022-2027)
7.3.6 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Verdiperstat (2022-2027)
7.3.7 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Zilucoplan (2022-2027)
7.3.8 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of CNM-Au8 (2022-2027)
7.3.9 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Trehalose (2022-2027)
7.3.10 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of MN-166 (2022-2027)
7.3.11 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of AMX0035 (2022-2027)
7.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Forecast by Application (2022-2027)
7.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Value and Growth Rate of Specialty Centers(2022-2027)
7.4.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Value and Growth Rate of Others(2022-2027)
7.5 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast Under COVID-19
8 AMYOTROPHIC LATERAL SCLEROSIS (ALS) TREATMENT MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Amyotrophic Lateral Sclerosis (ALS) Treatment Analysis
8.6 Major Downstream Buyers of Amyotrophic Lateral Sclerosis (ALS) Treatment Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Amyotrophic Lateral Sclerosis (ALS) Treatment Industry
9 PLAYERS PROFILES
9.1 Biogen
9.1.1 Biogen Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.1.3 Biogen Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 BrainStorm Cell Limited
9.2.1 BrainStorm Cell Limited Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.2.3 BrainStorm Cell Limited Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 AB Science
9.3.1 AB Science Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.3.3 AB Science Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Mitsubishi Tanabe Pharma Corporation
9.4.1 Mitsubishi Tanabe Pharma Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.4.3 Mitsubishi Tanabe Pharma Corporation Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Biohaven Pharmaceutical
9.5.1 Biohaven Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.5.3 Biohaven Pharmaceutical Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Sun Pharmaceutical Industries Ltd.
9.6.1 Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.6.3 Sun Pharmaceutical Industries Ltd. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Amylyx Pharmaceuticals Inc.
9.7.1 Amylyx Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.7.3 Amylyx Pharmaceuticals Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Ionis Pharmaceuticals
9.8.1 Ionis Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.8.3 Ionis Pharmaceuticals Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 CORESTEM, Inc
9.9.1 CORESTEM, Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.9.3 CORESTEM, Inc Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Amyotrophic Lateral Sclerosis (ALS) Treatment Market
1.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment by Type
1.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment by Application
1.3.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market, Region Wise (2017-2027)
1.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.4.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.4.4 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.4.5 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.4.6 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.4.8 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Status and Prospect (2017-2027)
1.5 Global Market Size of Amyotrophic Lateral Sclerosis (ALS) Treatment (2017-2027)
1.5.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Amyotrophic Lateral Sclerosis (ALS) Treatment Market
2 INDUSTRY OUTLOOK
2.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Drivers Analysis
2.4 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Development
3 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS (ALS) TREATMENT MARKET LANDSCAPE BY PLAYER
3.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Share by Player (2017-2022)
3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Market Share by Player (2017-2022)
3.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Average Price by Player (2017-2022)
3.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Gross Margin by Player (2017-2022)
3.5 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Competitive Situation and Trends
3.5.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Concentration Rate
3.5.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS (ALS) TREATMENT SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
4.5 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
4.6 China Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
4.7 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
4.8 India Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
4.9 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
4.10 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
4.11 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Under COVID-19
5 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS (ALS) TREATMENT SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Market Share by Type (2017-2022)
5.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Market Share by Type (2017-2022)
5.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Price by Type (2017-2022)
5.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Riluzole (2017-2022)
5.4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Edaravone (2017-2022)
5.4.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Tofersen/ BIIB067 (2017-2022)
5.4.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Arimoclomol (2017-2022)
5.4.5 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Ultomiris (Ravulizumab) (2017-2022)
5.4.6 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Verdiperstat (2017-2022)
5.4.7 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Zilucoplan (2017-2022)
5.4.8 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of CNM-Au8 (2017-2022)
5.4.9 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of Trehalose (2017-2022)
5.4.10 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of MN-166 (2017-2022)
5.4.11 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Growth Rate of AMX0035 (2017-2022)
6 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS (ALS) TREATMENT MARKET ANALYSIS BY APPLICATION
6.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Market Share by Application (2017-2022)
6.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Growth Rate of Specialty Centers (2017-2022)
6.3.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS (ALS) TREATMENT MARKET FORECAST (2022-2027)
7.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Price and Trend Forecast (2022-2027)
7.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Riluzole (2022-2027)
7.3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Edaravone (2022-2027)
7.3.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Tofersen/ BIIB067 (2022-2027)
7.3.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Arimoclomol (2022-2027)
7.3.5 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Ultomiris (Ravulizumab) (2022-2027)
7.3.6 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Verdiperstat (2022-2027)
7.3.7 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Zilucoplan (2022-2027)
7.3.8 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of CNM-Au8 (2022-2027)
7.3.9 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of Trehalose (2022-2027)
7.3.10 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of MN-166 (2022-2027)
7.3.11 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate of AMX0035 (2022-2027)
7.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Forecast by Application (2022-2027)
7.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Value and Growth Rate of Specialty Centers(2022-2027)
7.4.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Value and Growth Rate of Others(2022-2027)
7.5 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast Under COVID-19
8 AMYOTROPHIC LATERAL SCLEROSIS (ALS) TREATMENT MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Amyotrophic Lateral Sclerosis (ALS) Treatment Analysis
8.6 Major Downstream Buyers of Amyotrophic Lateral Sclerosis (ALS) Treatment Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Amyotrophic Lateral Sclerosis (ALS) Treatment Industry
9 PLAYERS PROFILES
9.1 Biogen
9.1.1 Biogen Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.1.3 Biogen Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 BrainStorm Cell Limited
9.2.1 BrainStorm Cell Limited Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.2.3 BrainStorm Cell Limited Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 AB Science
9.3.1 AB Science Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.3.3 AB Science Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Mitsubishi Tanabe Pharma Corporation
9.4.1 Mitsubishi Tanabe Pharma Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.4.3 Mitsubishi Tanabe Pharma Corporation Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Biohaven Pharmaceutical
9.5.1 Biohaven Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.5.3 Biohaven Pharmaceutical Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Sun Pharmaceutical Industries Ltd.
9.6.1 Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.6.3 Sun Pharmaceutical Industries Ltd. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Amylyx Pharmaceuticals Inc.
9.7.1 Amylyx Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.7.3 Amylyx Pharmaceuticals Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Ionis Pharmaceuticals
9.8.1 Ionis Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.8.3 Ionis Pharmaceuticals Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 CORESTEM, Inc
9.9.1 CORESTEM, Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Profiles, Application and Specification
9.9.3 CORESTEM, Inc Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and CAGR (%) Comparison by Type
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Development
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume by Player (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Share by Player (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Share by Player in 2021
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) by Player (2017-2022)
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Player (2017-2022)
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Price by Player (2017-2022)
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Region Wise (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Market Share, Region Wise in 2021
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD), Region Wise (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share, Region Wise in 2021
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume by Type (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Market Share by Type (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Market Share by Type in 2021
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) by Type (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type in 2021
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Price by Type (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Riluzole (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Riluzole (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Edaravone (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Edaravone (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Tofersen/ BIIB067 (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Tofersen/ BIIB067 (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Arimoclomol (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Arimoclomol (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Ultomiris (Ravulizumab) (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Ultomiris (Ravulizumab) (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Verdiperstat (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Verdiperstat (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Zilucoplan (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Zilucoplan (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of CNM-Au8 (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of CNM-Au8 (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Trehalose (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Trehalose (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of MN-166 (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of MN-166 (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of AMX0035 (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of AMX0035 (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption by Application (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Market Share by Application (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Revenue Market Share by Application (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Growth Rate of Specialty Centers (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Growth Rate of Others (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Price and Trend Forecast (2022-2027)
Figure USA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume Forecast, by Type
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Market Share Forecast, by Type
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) Forecast, by Type
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share Forecast, by Type
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Price Forecast, by Type
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Riluzole (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Riluzole (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Edaravone (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Edaravone (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Tofersen/ BIIB067 (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Tofersen/ BIIB067 (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Arimoclomol (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Arimoclomol (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Ultomiris (Ravulizumab) (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Ultomiris (Ravulizumab) (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Verdiperstat (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Verdiperstat (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Zilucoplan (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Zilucoplan (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of CNM-Au8 (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of CNM-Au8 (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Trehalose (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Trehalose (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of MN-166 (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of MN-166 (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of AMX0035 (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of AMX0035 (2022-2027)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Consumption Forecast, by Application
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Market Share Forecast, by Application
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) Forecast, by Application
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share Forecast, by Application
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Value (Million USD) and Growth Rate of Specialty Centers (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Biogen Profile
Table Biogen Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biogen Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate
Figure Biogen Revenue (Million USD) Market Share 2017-2022
Table BrainStorm Cell Limited Profile
Table BrainStorm Cell Limited Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BrainStorm Cell Limited Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate
Figure BrainStorm Cell Limited Revenue (Million USD) Market Share 2017-2022
Table AB Science Profile
Table AB Science Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AB Science Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate
Figure AB Science Revenue (Million USD) Market Share 2017-2022
Table Mitsubishi Tanabe Pharma Corporation Profile
Table Mitsubishi Tanabe Pharma Corporation Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mitsubishi Tanabe Pharma Corporation Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate
Figure Mitsubishi Tanabe Pharma Corporation Revenue (Million USD) Market Share 2017-2022
Table Biohaven Pharmaceutical Profile
Table Biohaven Pharmaceutical Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biohaven Pharmaceutical Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate
Figure Biohaven Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Sun Pharmaceutical Industr
Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and CAGR (%) Comparison by Type
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Development
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume by Player (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Share by Player (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Share by Player in 2021
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) by Player (2017-2022)
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Player (2017-2022)
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Price by Player (2017-2022)
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Region Wise (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Market Share, Region Wise in 2021
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD), Region Wise (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share, Region Wise in 2021
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume by Type (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Market Share by Type (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Market Share by Type in 2021
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) by Type (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type in 2021
Table Amyotrophic Lateral Sclerosis (ALS) Treatment Price by Type (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Riluzole (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Riluzole (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Edaravone (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Edaravone (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Tofersen/ BIIB067 (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Tofersen/ BIIB067 (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Arimoclomol (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Arimoclomol (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Ultomiris (Ravulizumab) (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Ultomiris (Ravulizumab) (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Verdiperstat (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Verdiperstat (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Zilucoplan (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Zilucoplan (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of CNM-Au8 (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of CNM-Au8 (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of Trehalose (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Trehalose (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of MN-166 (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of MN-166 (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate of AMX0035 (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of AMX0035 (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption by Application (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Market Share by Application (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Revenue Market Share by Application (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Growth Rate of Specialty Centers (2017-2022)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption and Growth Rate of Others (2017-2022)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Price and Trend Forecast (2022-2027)
Figure USA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Sales Volume Forecast, by Type
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume Market Share Forecast, by Type
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) Forecast, by Type
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share Forecast, by Type
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Price Forecast, by Type
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Riluzole (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Riluzole (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Edaravone (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Edaravone (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Tofersen/ BIIB067 (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Tofersen/ BIIB067 (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Arimoclomol (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Arimoclomol (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Ultomiris (Ravulizumab) (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Ultomiris (Ravulizumab) (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Verdiperstat (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Verdiperstat (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Zilucoplan (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Zilucoplan (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of CNM-Au8 (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of CNM-Au8 (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Trehalose (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of Trehalose (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of MN-166 (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of MN-166 (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of AMX0035 (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million USD) and Growth Rate of AMX0035 (2022-2027)
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Consumption Forecast, by Application
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Market Share Forecast, by Application
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue (Million USD) Forecast, by Application
Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share Forecast, by Application
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Value (Million USD) and Growth Rate of Specialty Centers (2022-2027)
Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Biogen Profile
Table Biogen Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biogen Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate
Figure Biogen Revenue (Million USD) Market Share 2017-2022
Table BrainStorm Cell Limited Profile
Table BrainStorm Cell Limited Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BrainStorm Cell Limited Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate
Figure BrainStorm Cell Limited Revenue (Million USD) Market Share 2017-2022
Table AB Science Profile
Table AB Science Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AB Science Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate
Figure AB Science Revenue (Million USD) Market Share 2017-2022
Table Mitsubishi Tanabe Pharma Corporation Profile
Table Mitsubishi Tanabe Pharma Corporation Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mitsubishi Tanabe Pharma Corporation Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate
Figure Mitsubishi Tanabe Pharma Corporation Revenue (Million USD) Market Share 2017-2022
Table Biohaven Pharmaceutical Profile
Table Biohaven Pharmaceutical Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biohaven Pharmaceutical Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Volume and Growth Rate
Figure Biohaven Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Sun Pharmaceutical Industr
